Multiple Myeloma Academy – Journal Club – Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial – Tuesday, March 10, 2026
Open to access this content










